Acknowledgement
We would like to thank Dr. Wei Zhao for valuable suggestions. We also thank all of the students who participated in this study. This work was supported by Guangdong Innovative and Entrepreneurial Research Team Program (2016ZT06S029), the Natural Science Foundation of Guangdong Province (2017A030312009) and the China Postdoctoral Science Foundation (2021M700961).
References
- Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl AJ, Pelletier JP. Osteoarthritis. Nat Rev Dis Primers 2016;2:16072
- Xie J, Wang Y, Lu L, Liu L, Yu X, Pei F. Cellular senescence in knee osteoarthritis: molecular mechanisms and therapeutic implications. Ageing Res Rev 2021;70:101413
- Jiang Y, Tuan RS. Origin and function of cartilage stem/progenitor cells in osteoarthritis. Nat Rev Rheumatol 2015;11:206-212 https://doi.org/10.1038/nrrheum.2014.200
- Zhu MM, Wang L, Yang D, Li C, Pang ST, Li XH, Li R, Yang B, Lian YP, Ma L, Lv QL, Jia XB, Feng L. Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway. Biomed Pharmacother 2019;117:109088
- Pan H, Lin Y, Dou J, Fu Z, Yao Y, Ye S, Zhang S, Wang N, Liu A, Li X, Zhang F, Chen D. Wedelolactone facilitates Ser/Thr phosphorylation of NLRP3 dependent on PKA signalling to block inflammasome activation and pyroptosis. Cell Prolif 2020;53:e12868
- Lim S, Jang HJ, Park EH, Kim JK, Kim JM, Kim EK, Yea K, Kim YH, Lee-Kwon W, Ryu SH, Suh PG. Wedelolactone inhibits adipogenesis through the ERK pathway in human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 2012;113:3436-3445 https://doi.org/10.1002/jcb.24220
- Liu YQ, Han XF, Bo JX, Ma HP. Wedelolactone enhances osteoblastogenesis but inhibits osteoclastogenesis through Sema3A/NRP1/PlexinA1 pathway. Front Pharmacol 2016;7:375
- Liu YQ, Hong ZL, Zhan LB, Chu HY, Zhang XZ, Li GH. Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway. Sci Rep 2016;6:32260
- Deng X, Liang LN, Zhu D, Zheng LP, Yu JH, Meng XL, Zhao YN, Sun XX, Pan TW, Liu YQ. Wedelolactone inhibits osteoclastogenesis but enhances osteoblastogenesis through altering different semaphorins production. Int Immunopharmacol 2018;60:41-49 https://doi.org/10.1016/j.intimp.2018.04.037
- Wang C, Song Y, Gu Z, Lian M, Huang D, Lu X, Feng X, Lu Q. Wedelolactone enhances odontoblast differentiation by promoting Wnt/β-catenin signaling pathway and suppressing NF-κB signaling pathway. Cell Reprogram 2018;20:236-244 https://doi.org/10.1089/cell.2018.0004
- Idris AI, Libouban H, Nyangoga H, Landao-Bassonga E, Chappard D, Ralston SH. Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo. Mol Cancer Ther 2009;8:2339-2347 https://doi.org/10.1158/1535-7163.MCT-09-0133
- Xu S, Liu X, Liu X, Shi Y, Jin X, Zhang N, Li X, Zhang H. Wedelolactone ameliorates Pseudomonas aeruginosa-induced inflammation and corneal injury by suppressing caspase-4/5/11/GSDMD-mediated non-canonical pyroptosis. Exp Eye Res 2021;211:108750
- Nehybova T, Smarda J, Daniel L, Brezovsky J, Benes P. Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling. J Steroid Biochem Mol Biol 2015;152:76-83 https://doi.org/10.1016/j.jsbmb.2015.04.019
- Benes P, Knopfova L, Trcka F, Nemajerova A, Pinheiro D, Soucek K, Fojta M, Smarda J. Inhibition of topoisomerase IIα: novel function of wedelolactone. Cancer Lett 2011;303:29-38 https://doi.org/10.1016/j.canlet.2011.01.002
- Deng H, Fang Y. Anti-inflammatory gallic Acid and wedelolactone are G protein-coupled receptor-35 agonists. Pharmacology 2012;89:211-219 https://doi.org/10.1159/000337184
- Romanchikova N, Trapencieris P. Wedelolactone targets EZH2-mediated histone H3K27 methylation in mantle cell lymphoma. Anticancer Res 2019;39:4179-4184 https://doi.org/10.21873/anticanres.13577
- Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676 https://doi.org/10.1016/j.cell.2006.07.024
- Nam Y, Rim YA, Ju JH. Chondrogenic pellet formation from cord blood-derived induced pluripotent stem cells. J Vis Exp 2017;(124):55988
- Li Y, Hai Y, Chen J, Liu T. Differentiating chondrocytes from peripheral blood-derived human induced pluripotent stem cells. J Vis Exp 2017;(125):55722
- Bi R, Yin Q, Mei J, Chen K, Luo X, Fan Y, Zhu S. Identification of human temporomandibular joint fibrocartilage stem cells with distinct chondrogenic capacity. Osteoarthritis Cartilage 2020;28:842-852 https://doi.org/10.1016/j.joca.2020.02.835
- Xu M, Stattin EL, Shaw G, Heinegard D, Sullivan G, Wilmut I, Colman A, Onnerfjord P, Khabut A, Aspberg A, Dockery P, Hardingham T, Murphy M, Barry F. Chondrocytes derived from mesenchymal stromal cells and induced pluripotent cells of patients with familial osteochondritis dissecans exhibit an endoplasmic reticulum stress response and defective matrix assembly. Stem Cells Transl Med 2016;5:1171-1181 https://doi.org/10.5966/sctm.2015-0384
- Zhu D, Deng X, Han XF, Sun XX, Pan TW, Zheng LP, Liu YQ. Wedelolactone enhances osteoblastogenesis through ERK- and JNK-mediated BMP2 expression and Smad/1/5/8 phosphorylation. Molecules 2018;23:561
- Soh R, Hardy A, Zur Nieden NI. The FOXO signaling axis displays conjoined functions in redox homeostasis and stemness. Free Radic Biol Med 2021;169:224-237 https://doi.org/10.1016/j.freeradbiomed.2021.04.022
- Akiyama H. Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 2008;18:213-219 https://doi.org/10.3109/s10165-008-0048-x
- Cao R, Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 2004;14:155-164 https://doi.org/10.1016/j.gde.2004.02.001
- Jiang C, Guo Q, Jin Y, Xu JJ, Sun ZM, Zhu DC, Lin JH, Tian NF, Sun LJ, Zhang XL, Wu YS. Inhibition of EZH2 ameliorates cartilage endplate degeneration and attenuates the progression of intervertebral disc degeneration via demethylation of Sox-9. EBioMedicine 2019;48:619-629 https://doi.org/10.1016/j.ebiom.2019.10.006
- Ludikhuize MC, Meerlo M, Gallego MP, Xanthakis D, Burgaya Julia M, Nguyen NTB, Brombacher EC, Liv N, Maurice MM, Paik JH, Burgering BMT, Rodriguez Colman MJ. Mitochondria define intestinal stem cell differentiation downstream of a FOXO/Notch axis. Cell Metab 2020;32:889-900.e7 https://doi.org/10.1016/j.cmet.2020.10.005
- Kim DY, Hwang I, Muller FL, Paik JH. Functional regulation of FoxO1 in neural stem cell differentiation. Cell Death Differ 2015;22:2034-2045 https://doi.org/10.1038/cdd.2015.123
- Guerit D, Brondello JM, Chuchana P, Philipot D, Toupet K, Bony C, Jorgensen C, Noel D. FOXO3A regulation by miRNA-29a controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation. Stem Cells Dev 2014;23:1195-1205 https://doi.org/10.1089/scd.2013.0463
- Djouad F, Bony C, Canovas F, Fromigue O, Reme T, Jorgensen C, Noel D. Transcriptomic analysis identifies Foxo3A as a novel transcription factor regulating mesenchymal stem cell chrondrogenic differentiation. Cloning Stem Cells 2009;11:407-416 https://doi.org/10.1089/clo.2009.0013
- Kurakazu I, Akasaki Y, Hayashida M, Tsushima H, Goto N, Sueishi T, Toya M, Kuwahara M, Okazaki K, Duffy T, Lotz MK, Nakashima Y. FOXO1 transcription factor regulates chondrogenic differentiation through transforming growth factor β1 signaling. J Biol Chem 2019;294:17555-17569 https://doi.org/10.1074/jbc.RA119.009409
- Zheng M, Cao MX, Luo XJ, Li L, Wang K, Wang SS, Wang HF, Tang YJ, Tang YL, Liang XH. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells. J Cell Mol Med 2019;23:6942-6954 https://doi.org/10.1111/jcmm.14579
- Yu Y, Deng P, Yu B, Szymanski JM, Aghaloo T, Hong C, Wang CY. Inhibition of EZH2 promotes human embryonic stem cell differentiation into mesoderm by reducing H3K-27me3. Stem Cell Reports 2017;9:752-761 Erratum in: Stem Cell Reports 2018;11:1579-1580 https://doi.org/10.1016/j.stemcr.2018.11.013
- Rougeot J, Chrispijn ND, Aben M, Elurbe DM, Andralojc KM, Murphy PJ, Jansen PWTC, Vermeulen M, Cairns BR, Kamminga LM. Maintenance of spatial gene expression by Polycomb-mediated repression after formation of a vertebrate body plan. Development 2019;146:dev178590
- Camilleri ET, Dudakovic A, Riester SM, Galeano-Garces C, Paradise CR, Bradley EW, McGee-Lawrence ME, Im HJ, Karperien M, Krych AJ, Westendorf JJ, Larson AN, van Wijnen AJ. Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development. J Biol Chem 2018;293:19001-19011 https://doi.org/10.1074/jbc.RA118.003909
- Chen L, Wu Y, Wu Y, Wang Y, Sun L, Li F. The inhibition of EZH2 ameliorates osteoarthritis development through the Wnt/β-catenin pathway. Sci Rep 2016;6:29176
- Li F, Chen S, Yu J, Gao Z, Sun Z, Yi Y, Long T, Zhang C, Li Y, Pan Y, Qin C, Long W, Liu Q, Zhao W. Interplay of m6 A and histone modifications contributes to temozolomide resistance in glioblastoma. Clin Transl Med 2021;11:e553
- Asenjo HG, Gallardo A, Lopez-Onieva L, Tejada I, Martorell-Marugan J, Carmona-Saez P, Landeira D. Polycomb regulation is coupled to cell cycle transition in pluripotent stem cells. Sci Adv 2020;6:eaay4768